Navigation Links
Microbia, Inc. Names Alex Chu as Vice President of Process Development
Date:5/27/2009

Microbia, Inc. (formerly Microbia Precision Engineering), an emerging leader in the production of sustainable, specialty ingredients and biomaterials from fermentation technology, announced that Alex Chu has joined the company as vice president of process development. Alex is the former vice president of manufacturing and process development for Bristol-Myers Squibb and will lead Microbia's process development and manufacturing initiatives. For more information about Microbia, please go to www.microbia.com.

Lexington, Mass. (PRWEB) May 27, 2009 -- Microbia, Inc. (formerly Microbia Precision Engineering) has appointed Alex Chu as vice president of process development. Dr. Chu's responsibilities will include directing all process development activities from laboratories to commercial manufacturing, including the launch of Microbia's pipeline of naturally derived carotenoids for the human and animal food ingredient and nutritional supplement markets.

"Microbia is thrilled to welcome Alex to the Microbia team to lead the process development and manufacturing of our pipeline of innovative, cost-effective food ingredients and biomaterials," said Richard Bailey, Ph.D., CEO of Microbia. "Alex brings a wealth of experience in biomanufacturing and process development, along with a unique combination of science and management expertise that will facilitate our delivery of commercially viable products to the market."

"I'm pleased to be a part of Microbia's strong leadership team," said Dr. Chu. "I look forward to the opportunity to help Microbia advance as a leader in the commercialization of a new generation of innovative, sustainable, high value ingredients and biochemicals."

Alex Chu brings diverse experience in bioprocess development and manufacturing to Microbia. He was most recently the vice president of manufacturing and process development at Adnexus Therapeutics, Bristol-Myers Squibb. Prior to this, he held multiple scientific and management positions at Abbott Laboratories and Abbott BioResearch Center, including director of manufacturing program management and director, process development, Pharma. Alex earned a bachelor's degree in chemical engineering from National Taiwan University and a Ph.D. in biochemical engineering from the University of Wisconsin-Madison.

ABOUT MICROBIA (WWW.MICROBIA.COM)
Microbia, (formerly Microbia Precision Engineering) is an industrial biotechnology company applying proprietary metabolic engineering utilizing fermentation technology to create cost-effective, renewable specialty ingredients and biomaterials. Microbia will develop and market its products through direct sales and strategic alliances, including an ongoing multi-product joint development and commercialization agreement with Tate & Lyle Investments, Ltd. Carotenoids will be the first products launched from Microbia's diverse pipeline of specialty ingredients, biopolymers and other biomaterials. Microbia, Inc., based in Lexington, Massachusetts, was established in 2006 as an operationally independent subsidiary of Ironwood Pharmaceuticals, Inc.

# # #

Read the full story at http://www.prweb.com/releases/Microbia/Alex_Chu/prweb2462154.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related biology technology :

1. Microbia, Inc. Names Mike Doyle as Senior Vice President and General Manager, Nutrition Ingredients
2. Premier Research Names Hal Ward, R.Ph., PharmD as Executive Director, Global Pharmacovigilance
3. Pulmonary Hypertension Association Names Dr. Nicholas Hill Recipient of 2009 Award of Excellence in Pulmonary Arterial Hypertension (PAH) Care
4. Orexigen(R) Therapeutics Names Michael Scaife Senior Vice President of Regulatory Affairs and Product Development, Contrave(R) Program
5. Hospira Names Brian Meadows Supply Chain Chief
6. Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer
7. Fina Technologies Names Spotfire Founder Christopher Ahlberg to Board of Directors
8. Codexis Names Lori Giver VP Systems Biology
9. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
10. Thomson Reuters Names Hottest Researchers and Papers of 2007-2008
11. VITAS Innovative Hospice Care(R) Names Christopher Rieder Senior Vice President and Chief Information Officer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Microbia, Inc. Names Alex Chu as Vice President of Process Development 
(Date:10/12/2017)... ... October 12, 2017 , ... BioMedGPS ... the addition of its newest module, US Hemostats & Sealants. , SmartTRAK’s US ... absorbable hemostats, fibrin sealants, synthetic sealants and biologic sealants used in surgical applications. ...
(Date:10/11/2017)... ... October 11, 2017 , ... The ... context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The ... transformative for performing systematic gain-of-function studies. , This complement to loss-of-function studies, ...
(Date:10/11/2017)... 11, 2017  VMS BioMarketing, a leading provider of patient ... Clinical Nurse Educator (CNE) network, which will launch this week. ... among health care professionals to enhance the patient care experience ... and other health care professionals to help women who have ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator ... osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular STAT3 ...
Breaking Biology Technology:
(Date:4/5/2017)... , April 5, 2017  The Allen Institute ... Allen Cell Explorer: a one-of-a-kind portal and dynamic digital ... 3D imaging data, the first application of deep learning ... human stem cell lines and a growing suite of ... platform for these and future publicly available resources created ...
(Date:4/3/2017)... April 3, 2017  Data captured by ... platform, detected a statistically significant association between ... to treatment and objective response of cancer ... to predict whether cancer patients will respond ... as well as to improve both pre-infusion potency ...
(Date:3/29/2017)... -- higi, the health IT company that operates the largest ... , today announced a Series B investment from BlueCross ... new investment and acquisition accelerates higi,s strategy to create ... health activities through the collection and workflow integration of ... and secures data today on behalf of over 36 ...
Breaking Biology News(10 mins):